Fiskars Oyj Abp (FRA:A8X)

Inozyme Pharma Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	72.1	60.8	127.3	115.8	31.5	62.5
Cash & Short-Term Investments	72.1	60.8	127.3	115.8	31.5	62.5
Cash Growth	-16.45%	-52.24%	9.93%	267.62%	-49.60%	564.89%
Accounts Receivable	169.5	188.9	177.2	170.5	182.7	183.7
Other Receivables	61.5	55.1	48.1	50.2	30.2	36.1
Receivables	231.1	244	226.7	222.4	212.9	219.8
Inventory	345.5	330.7	364	364.7	272.9	207.4
Prepaid Expenses	-	-	-	-	19	23.2
Other Current Assets	-0.1	5.8	8.1	5.7	39	-
Total Current Assets	648.6	641.3	726.1	708.6	575.3	512.9
Property, Plant & Equipment	359.9	363.4	357.9	303.4	297.1	283.5
Long-Term Investments	28.5	33.3	34.4	32.5	35.7	25.2
Goodwill	218.6	225.9	220.1	221.2	219.1	213.7
Other Intangible Assets	346.9	378.3	371.7	278.6	270.2	268.2
Long-Term Deferred Tax Assets	44.7	48.8	28.4	31.9	27.5	27.4
Other Long-Term Assets	21.7	20.1	16.3	12.1	10.6	11.1
Total Assets	1,669	1,711	1,755	1,588	1,436	1,342
Accounts Payable	88	88.4	102.1	83.9	139.3	100.2
Accrued Expenses	-	38	39.8	38.6	49.2	49.9
Short-Term Debt	-	1	-	-	14.2	0.9
Current Portion of Long-Term Debt	150.4	75.1	92.5	195.2	50.2	60.3
Current Portion of Leases	32.8	33.6	33.3	22.5	22.6	22.7
Current Income Taxes Payable	6.2	14.4	6.7	3.8	3.2	5.5
Current Unearned Revenue	-	49.8	49.7	47.3	72.8	62.1
Other Current Liabilities	198	112.2	100.8	98	123.9	103.3
Total Current Liabilities	475.4	412.5	424.9	489.3	475.4	404.9
Long-Term Debt	332.7	331	330.7	130.4	0.7	51.2
Long-Term Leases	112.6	113.9	117.4	92.9	88.9	71.8
Long-Term Deferred Tax Liabilities	38.4	36.9	38.8	34.5	32.1	31.2
Other Long-Term Liabilities	6.8	8	7.3	6.5	9.3	8.2
Total Liabilities	977.4	914.6	931.2	764.4	619.2	580.4
Common Stock	77.5	77.5	77.5	77.5	77.5	77.5
Retained Earnings	617.9	699.2	736.2	730.9	734	693.6
Treasury Stock	-3	-2.1	-3	-6.7	-7.2	-7.2
Comprehensive Income & Other	-5.1	17.6	9.2	18.1	7.8	-6.1
Total Common Equity	687.3	792.2	819.9	819.8	812.1	757.8
Minority Interest	4.2	4.3	3.8	4.1	4.2	3.8
Shareholders' Equity	691.5	796.5	823.7	823.9	816.3	761.6
Total Liabilities & Equity	1,669	1,711	1,755	1,588	1,436	1,342
Total Debt	628.5	554.6	573.9	441	176.6	206.9
Net Cash (Debt)	-556.4	-493.8	-446.6	-325.2	-145.1	-144.4
Net Cash Per Share	-6.75	-6.11	-5.53	-4.01	-1.78	-1.77
Filing Date Shares Outstanding	80.8	80.86	80.8	80.58	81.47	81.47
Total Common Shares Outstanding	80.8	80.86	80.8	80.58	81.47	81.47
Working Capital	173.2	228.8	301.2	219.3	99.9	108
Book Value Per Share	8.51	9.80	10.15	10.17	9.97	9.30
Tangible Book Value	121.8	188	228.1	320	322.8	275.9
Tangible Book Value Per Share	1.51	2.33	2.82	3.97	3.96	3.39
Land	-	21.1	20.8	20.9	21	21
Buildings	-	112.7	105.7	92	91.9	89.2
Machinery	-	146.5	131.6	123.5	111.3	111.7
Construction In Progress	-	23.2	17.3	14.3	10.4	6.8

Source: S&P Global Market Intelligence. Standard template. Financial Sources.